Methaemoglobinaemia

Reviewed and revised 14 September 2014

OVERVIEW

Methaemoglobinaemia is the state of excessive methaemoglobin in the blood

  • methaemoglobin is an altered state of Hb where ferrous ions (Fe2+) of haem are oxidised to the ferric state (Fe3+) and rendered unable to bind O2
  • normal level is < 1.5%

CAUSES

Congenital

  • cytochrome b5 reductase deficiency
  • haemoglobin M disease

Acquired (toxin/drugs)

  • aniline dyes
  • benzene derivatives
  • chloroquine
  • dapsone
  • prilocaine
  • metoclopramide
  • nitrites (nitroglycerin, NO, sodium nitroprusside)
  • sulphonamides

CLINICAL FEATURES

  • cyanosis
  • symptoms and signs of decreased oxygen delivery e.g. chest pain, dyspnea, altered metal state, end organ damage
  • SpO2 reading 85-90%
  • blood samples typically have a chocolate brown hue
  • Normal PaO2

INVESTIGATIONS

  • confirmation via ABG (co-oximetry +/- specific assay + history of exposure)
  • high metHb

MANAGEMENT

Resuscitation

  • high flow O2 (to ensure available Hb is saturated well)

Specific therapy

  • congenital
    — avoid precipitants
  • cessation of precipitants
  • methylene blue (1-2mg/kg over 5 minutes) provides an artificial electron acceptor to facilitate the reduction of MetHb via the NADPH-dependent pathway; give if:
    — symptomatic
    — consider if asymptomatic with >20% MetHb, or >10% if risk factors such as anaemia or ischemic heart disease
  • repeat methylene blue at 30-60 min if inadequate response
  • alternatives to methylene blue:
    —ascorbic acid (if methylene blue contra-indicated, e.g. G6PD deficiency)
    — exchange transfusion
    — hyperbaric oxygen

Supportive care and monitoring

REASONS FOR FAILURE OF METHYLENE BLUE

Consider the following if MetHb levels do not fall with methylene blue:

  • massive ongoing exposure to an oxidizing agent
  • sulfhaemoglobinemia (e.g. dapsone, sulfonamides)
  • G6PD deficiency
  • methaemoglobin reductase deficiency
  • abnormal haemoglobin
  • excessive methylene blue (paradoxical effect in high doses)

CCC Toxicology Series

CCC 700 6

Critical Care

Compendium

Chris is an Intensivist and ECMO specialist at The Alfred ICU, where he is Deputy Director (Education). He is a Clinical Adjunct Associate Professor at Monash University, the Lead for the  Clinician Educator Incubator programme, and a CICM First Part Examiner.

He is an internationally recognised Clinician Educator with a passion for helping clinicians learn and for improving the clinical performance of individuals and collectives. He was one of the founders of the FOAM movement (Free Open-Access Medical education) has been recognised for his contributions to education with awards from ANZICS, ANZAHPE, and ACEM.

His one great achievement is being the father of three amazing children.

On Bluesky, he is @precordialthump.bsky.social and on the site that Elon has screwed up, he is @precordialthump.

| INTENSIVE | RAGE | Resuscitology | SMACC

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.